Showing results (401-410 of 855) with videos related to

Sort By:
Pageof 86
Plos One|January 26, 2016
Panethnic Differences in Blood Pressure in Europe: A Systematic Review and Meta-AnalysisPietro Amedeo Modesti, Gianpaolo Reboldi, Francesco P Cappuccio, et al.
Kidney International|April 21, 2005
Inhibition of the chemokine receptor CXCR2 prevents kidney graft function deterioration due to ischemia/reperfusionDaniela Cugini, Nadia Azzollini, Elena Gagliardini, et al.
Kidney International|November 25, 2003
ACE inhibition limits chronic injury of kidney transplant even with treatment started when lesions are establishedMarina Noris, Marilena Mister, Anna Pezzotta, et al.
Kidney International|June 16, 2005
Safety and efficacy of long-acting somatostatin treatment in autosomal-dominant polycystic kidney diseasePiero Ruggenenti, Andrea Remuzzi, Patrizia Ondei, et al.
Journal of Hypertension|October 8, 2009
Antihypertensive effects of double the maximum dose of valsartan in African-American patients with type 2 diabetes mellitus and albuminuriaMatthew R Weir, Norman K Hollenberg, Dion H Zappe, et al.
Plos One|August 23, 2013
Renal expression of FGF23 in progressive renal disease of diabetes and the effect of ACE inhibitorCristina Zanchi, Monica Locatelli, Ariela Benigni, et al.
Plos One|May 21, 2015
Sirtuin3 Dysfunction Is the Key Determinant of Skeletal Muscle Insulin Resistance by Angiotensin IIDaniela Macconi, Luca Perico, Lorena Longaretti, et al.
Journal of the American Society of Nephrology : JASN|November 22, 2002
How to fully protect the kidney in a severe model of progressive nephropathy: a multidrug approachCarla Zoja, Daniela Corna, Davide Camozzi, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 1, 2017
BRAF Signaling Pathway Inhibition, Podocyte Injury, and Nephrotic SyndromeLuca Perico, Mario Mandalà, Arrigo Schieppati, et al.
Pageof 86